A prevalence study of primary dystonia in eight European countries
- PMID: 11127535
- DOI: 10.1007/s004150070094
A prevalence study of primary dystonia in eight European countries
Abstract
There have been few epidemiological studies of dystonia. Most previous studies have provided estimates based on few cases. A European prevalence study was undertaken to provide more precise rates of dystonia by pooling data from eight European countries. Diagnosed cases were ascertained by adult neurologists with specialist movement disorder (and botulinum toxin) clinics. The crude annual period prevalence rate (1996-1997) for primary dystonia was 152 per million (95% confidence interval 142-162), with focal dystonia having the highest rate of 117 per million (108-126). Prevalence rates for cervical dystonia, blepharospasm and writer's cramp were as follows: 57 (95% confidence interval 51-63), 36 (31-41), and 14 (11-17). The age-adjusted relative rates were significantly higher in women than in men for segmental and focal dystonias with the exception of writer's cramp. Comparing rates between centres demonstrated significant variations for cervical dystonia, blepharospasm and writer's cramp, probably due to methodological differences. Our results provide the first data on the prevalence of primary dystonia and its subtypes across several European countries. Due to under-ascertainment of cases, our rates should be seen as conservative and an under-estimate of the true prevalence of dystonia.
Similar articles
-
Epidemiology of focal and generalized dystonia in Rochester, Minnesota.Mov Disord. 1988;3(3):188-94. doi: 10.1002/mds.870030302. Mov Disord. 1988. PMID: 3264051
-
[Epidemiological analysis of primary dystonia in Szczecin and Gdańsk regions].Neurol Neurochir Pol. 2003;37 Suppl 5:231-9. Neurol Neurochir Pol. 2003. PMID: 15098351 Polish.
-
Sex-related influences on the frequency and age of onset of primary dystonia. Epidemiologic Study of Dystonia in Europe (ESDE) Collaborative Group.Neurology. 1999 Nov 10;53(8):1871-3. doi: 10.1212/wnl.53.8.1871. Neurology. 1999. PMID: 10563645
-
Dystonia.Handb Clin Neurol. 2013;116:485-9. doi: 10.1016/B978-0-444-53497-2.00038-3. Handb Clin Neurol. 2013. PMID: 24112917 Review.
-
Writer's cramp--a focal dystonia: etiology, diagnosis, and treatment.J Hand Surg Am. 1993 May;18(3):541-4. doi: 10.1016/0363-5023(93)90109-G. J Hand Surg Am. 1993. PMID: 8515033 Review.
Cited by
-
Safety and Effectiveness of OnabotulinumtoxinA in Patients with Laryngeal Dystonia: Final Report of a 52-Week, Multicenter Postmarketing Surveillance Study.Toxins (Basel). 2023 Sep 5;15(9):553. doi: 10.3390/toxins15090553. Toxins (Basel). 2023. PMID: 37755979 Free PMC article.
-
Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study.Neuropsychiatr Dis Treat. 2018 Apr 26;14:1119-1124. doi: 10.2147/NDT.S152252. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 29731634 Free PMC article.
-
Increased sensorimotor and superior parietal activation correlate with reduced writing dysfluency in writer's cramp dystonia.medRxiv [Preprint]. 2025 Mar 21:2025.03.20.25324331. doi: 10.1101/2025.03.20.25324331. medRxiv. 2025. PMID: 40166535 Free PMC article. Preprint.
-
The effect on blink frequency of a selective blue-filtering photochromic lens in patients with benign essential blepharospasm.Front Neurol. 2023 Dec 18;14:1301947. doi: 10.3389/fneur.2023.1301947. eCollection 2023. Front Neurol. 2023. PMID: 38164199 Free PMC article.
-
Botulinum toxin A (Dysport®): in dystonias and focal spasticity.Drugs. 2011 May 28;71(8):1043-58. doi: 10.2165/11206340-000000000-00000. Drugs. 2011. PMID: 21668041 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical